Skip to main
GRCE
GRCE logo

GRCE Market Capitalization Overview

Market Cap: $41.77M as of Jul 2, 2025

$41.77M
Past Month+$3.73M (9.78%)
As of Jul 2, 2025, GRCE has a market capitalization of $41.77M. Over the past 30 days, its market cap has increased by 6.19%, while in the last 12 months, it has increased by 10.12%.

Market capitalization represents the total value of Grace Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

GRCE Market Cap Formula = Stock Price * Shares Outstanding

The market cap of GRCE helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

GRCE Market Cap History

DateMarket CapChange
Jul 1, 2025$40.94M+6.19%
Jun 2, 2025$38.55M+3.69%
May 1, 2025$37.18M+19.91%
Apr 1, 2025$31.01M-12.80%
Mar 3, 2025$35.56M+8.89%
Feb 3, 2025$32.66M-19.50%
Jan 2, 2025$40.56M+21.21%

GRCE End of Year Market Cap History

DateMarket CapChange
2025$41.77M+10.12%
2024$37.93M

FAQs About Grace Therapeutics Inc (GRCE) Market Cap

As of Jul 2, 2025, the market capitalization of GRCE is $41.77M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Grace Therapeutics Inc’s market capitalization has increased by 9.78%, changing from $38.05M to $41.77M as of Jul 2, 2025.

In the last 3 months, Grace Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Grace Therapeutics Inc’s market capitalization increased from – in January to $37.93M in December, reflecting a — change.

Grace Therapeutics Inc (GRCE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.